Search

Your search keyword '"Fargion, Silvia"' showing total 814 results

Search Constraints

Start Over You searched for: Author "Fargion, Silvia" Remove constraint Author: "Fargion, Silvia"
814 results on '"Fargion, Silvia"'

Search Results

1. Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors

2. Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades

5. Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP)

9. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

10. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

13. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

14. Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors

15. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis

16. A sweet fever

18. Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades

19. Metabolic associated fatty liver disease: different impact of the three defining criteria on the hepatic and cardiovascular complications

20. SGLT2 inhibitors improve hepatic fibrosis assessed by Fibroscan in NAFLD patients with type 2 diabetes: a five-year follow-up study

22. Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study

24. Theories and practices in social work : practitioners' representations of contract work

26. A “systems medicine” approach to the study of non-alcoholic fatty liver disease

27. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease

29. AISF position paper on liver disease and pregnancy

30. Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

31. Statin use and non-alcoholic steatohepatitis in at risk individuals

33. Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study

36. Coagulation imbalance is associated with hepatic fibrosis and vascular complications in patients with type2 diabetes and NAFLD

43. Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown

45. The rs2294918 E434K Variant Modulates Patatin-Like Phospholipase Domain-Containing 3 Expression and Liver Damage

46. DEPDC5 Variants Increase Fibrosis Progression in Europeans with Chronic Hepatitis C Virus Infection

49. Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register

Catalog

Books, media, physical & digital resources